Asymptomatic Joint Bleeding and Joint Health in Hemophilia: A Review of Variables, Methods, and Biomarkers

References

• van Vulpen LFD, Holstein K, Martinoli C. Joint disease in haemophilia: pathophysiology, pain and imaging. Haemophilia. 2018;24(S6):44–49. doi:10.1111/hae.13449
   PubMed Web of Science ®Google Scholar
• Rodriguez-Merchan EC. Musculo-skeletal manifestations of haemophilia. Blood Rev. 2016;30(5):401–409. doi:10.1016/j.blre.2016.04.008
   PubMed Web of Science ®Google Scholar
• Chen CM, Huang KC, Chen CC, et al. The impact of joint range of motion limitations on health-related quality of life in patients with haemophilia A: a prospective study. Haemophilia. 2015;21(3):e176–e184. doi:10.1111/hae.12644
   PubMed Web of Science ®Google Scholar
• Holstein K, von Mackensen S, Bokemeyer C, Langer F. The impact of social factors on outcomes in patients with bleeding disorders. Haemophilia. 2016;22(1):46–53. doi:10.1111/hae.12760
   PubMed Web of Science ®Google Scholar
• Khair K, Holland M, Bladen M, Griffioen A, McLaughlin P, von Mackensen S. Study of physical function in adolescents with haemophilia: the SO-FIT study. Haemophilia. 2017;23(6):918–925. doi:10.1111/hae.13323
   Web of Science ®Google Scholar
• O’Hara J, Walsh S, Camp C, et al. The impact of severe haemophilia and the presence of target joints on health-related quality-of-life. Health Qual Life Outcomes. 2018;16(1):84. doi:10.1186/s12955-018-0908-9
   PubMed Web of Science ®Google Scholar
• Rodriguez-Merchan EC. Treatment of musculo-skeletal pain in haemophilia. Blood Rev. 2018;32(2):116–121. doi:10.1016/j.blre.2017.09.004
   PubMed Web of Science ®Google Scholar
• Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357(6):535–544. doi:10.1056/NEJMoa067659
   PubMed Web of Science ®Google Scholar
• Olivieri M, Kurnik K, Pfluger T, Bidlingmaier C. Identification and long-term observation of early joint damage by magnetic resonance imaging in clinically asymptomatic joints in patients with haemophilia A or B despite prophylaxis. Haemophilia. 2012;18(3):369–374. doi:10.1111/j.1365-2516.2011.02682.x
   PubMed Web of Science ®Google Scholar
• Kraft J, Blanchette V, Babyn P, et al. Magnetic resonance imaging and joint outcomes in boys with severe hemophilia A treated with tailored primary prophylaxis in Canada. J Thromb Haemost. 2012;10(12):2494–2502. doi:10.1111/jth.12025
   PubMed Web of Science ®Google Scholar
• Di Minno MND, Iervolino S, Soscia E, et al. Magnetic resonance imaging and ultrasound evaluation of “healthy” joints in young subjects with severe haemophilia A. Haemophilia. 2013;19(3):e167–e173. doi:10.1111/hae.12107
   Web of Science ®Google Scholar
• Srivastava A, Santagostino E, Dougall A, et al. WFH guidelines for the management of hemophilia, 3rd edition. Haemophilia. 2020;26(Suppl 6):1–158. doi:10.1111/hae.14046
   PubMed Web of Science ®Google Scholar
• Rodriguez-Merchan EC, Jimenez-Yuste V, Aznar JA, et al. Joint protection in haemophilia. Haemophilia. 2011;17(S2):1–23. doi:10.1111/j.1365-2516.2011.02615.x
   Web of Science ®Google Scholar
• Manco-Johnson MJ, Lundin B, Funk S, et al. Effect of late prophylaxis in hemophilia on joint status: a randomized trial. J Thromb Haemost. 2017;15(11):2115–2124. doi:10.1111/jth.13811
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG; Prisma Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097
   PubMed Web of Science ®Google Scholar
• Fischer K, van der Bom JG, Mauser-Bunschoten EP, et al. Endogenous clotting factor activity and long-term outcome in patients with moderate haemophilia. Thromb Haemost. 2000;84(6):977–980. doi:10.1055/s-0037-1614159
   Web of Science ®Google Scholar
• den Uijl IEM, Biesma D, Grobbee D, Fischer K. Turning severe into moderate haemophilia by prophylaxis: are we reaching our goal? Blood Transfus. 2013;11(3):364–369. doi:10.2450/2012.0092-12
   Web of Science ®Google Scholar
• Gilbert L, Rollins L, Hilmes M, et al. Haemophilia A carriers demonstrate pathological and radiological evidence of structural joint changes. Haemophilia. 2014;20(6):e426–e429. doi:10.1111/hae.12535
   PubMed Web of Science ®Google Scholar
• Sidonio RF, Mili FD, Li T, et al. Females with FVIII and FIX deficiency have reduced joint range of motion. Am J Hematol. 2014;89(8):831–836. doi:10.1002/ajh.23754
   PubMed Web of Science ®Google Scholar
• Soucie JM, Monahan PE, Kulkarni R, Konkle BA, Mazepa MA. The frequency of joint hemorrhages and procedures in nonsevere hemophilia A vs B. Blood Adv. 2018;2(16):2136–2144. doi:10.1182/bloodadvances.2018020552
   PubMed Web of Science ®Google Scholar
• Osooli M, Donfield SM, Carlsson KS, et al. Joint comorbidities among Swedish carriers of haemophilia: a register-based cohort study over 22 years. Haemophilia. 2019;25(5):845–850. doi:10.1111/hae.13831
   PubMed Web of Science ®Google Scholar
• den Uijl IEM, Biesma D, Grobbee D, Fischer K. Outcome in moderate haemophilia. Blood Transfus. 2014;12(Suppl 1):s330–s336. doi:10.2450/2012.0091-12
   PubMed Web of Science ®Google Scholar
• Osooli M, Lovdahl S, Steen Carlsson K, et al. Comparative burden of arthropathy in mild haemophilia: a register-based study in Sweden. Haemophilia. 2017;23(2):e79–e86. doi:10.1111/hae.13166
   Web of Science ®Google Scholar
• Gomperts ED, Schwarz J, Donfield SM, et al. The importance of genetic factors for the development of arthropathy: a longitudinal study of children and adolescents with haemophilia A. Thromb Haemost. 2017;117(2):277–285. doi:10.1160/TH16-06-0440
   PubMed Web of Science ®Google Scholar
• Khanum F, Bowen DJ, Kerr BC, Collins PW. Joint health scores in a haemophilia A cohort from Pakistan with minimal or no access to factor VIII concentrate: correlation with thrombin generation and underlying mutation. Haemophilia. 2014;20(3):426–434. doi:10.1111/hae.12326
   Web of Science ®Google Scholar
• Jayandharan GR, Nair SC, Poonnoose PM, et al. Polymorphism in factor VII gene modifies phenotype of severe haemophilia. Haemophilia. 2009;15(6):1228–1236. doi:10.1111/j.1365-2516.2009.02080.x
   Web of Science ®Google Scholar
• Shankarkumar U, Ghosh K, Mohanty D. Novel HLA B*2714 and B*2708 allele associations in seronegative spondarthritis patients and haemophilia patients with chronic synovitis in India. Tissue Antigens. 2003;62(2):175–178. doi:10.1034/j.1399-0039.2003.00074.x
   Google Scholar
• Ghosh K, Shankarkumar U, Shetty S, Mohanty D. Chronic synovitis and HLA B27 in patients with severe haemophilia. Lancet. 2003;361(9361):933–934. doi:10.1016/S0140-6736(03)12763-8
   Web of Science ®Google Scholar
• Cruz E, Porto G, Morais S, Campos M, de Sousa M. HFE mutations in the pathobiology of hemophilic arthropathy. Blood. 2005;105(8):3381–3382. doi:10.1182/blood-2004-11-4342
   Web of Science ®Google Scholar
• López-Jiménez JJ, Ortega-Cervantes R, Luna-Záizar H, et al. Genetic biomarkers related to hemarthrosis, inflammation, and cartilage structure in pediatric patients with hemophilic arthropathy. Mol Genet Genomic Med. 2019;7(11):e979. doi:10.1002/mgg3.979
   Web of Science ®Google Scholar
• Fischer K, van der Bom JG, Molho P, et al. Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcome. Haemophilia. 2002;8(6):745–752. doi:10.1046/j.1365-2516.2002.00695.x
   PubMed Web of Science ®Google Scholar
• Collins P, Faradji A, Morfini M, Enriquez MM, Schwartz L. Efficacy and safety of secondary prophylactic vs. on-demand sucrose-formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13-month crossover study. J Thromb Haemost. 2010;8(1):83–89. doi:10.1111/j.1538-7836.2009.03650.x
   PubMed Web of Science ®Google Scholar
• Gringeri A, Lundin B, von Mackensen S, Mantovani L, Mannucci PM; Esprit Study Group. A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT study). J Thromb Haemost. 2011;9(4):700–710. doi:10.1111/j.1538-7836.2011.04214.x
   PubMed Web of Science ®Google Scholar
• Tagliaferri A, Feola G, Molinari AC, et al. Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: the POTTER study. Thromb Haemost. 2015;114(1):35–45. doi:10.1160/TH14-05-0407
   Web of Science ®Google Scholar
• Oldenburg J, Zimmermann R, Katsarou O, et al. Controlled, cross-sectional MRI evaluation of joint status in severe haemophilia A patients treated with prophylaxis vs. on demand. Haemophilia. 2015;21(2):171–179. doi:10.1111/hae.12539
   Web of Science ®Google Scholar
• Manco-Johnson MJ, Soucie JM, Gill JC. Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance project. Blood. 2017;129(17):2368–2374. doi:10.1182/blood-2016-02-683169
   PubMed Web of Science ®Google Scholar
• Oldenburg J, Kulkarni R, Srivastava A, et al. Improved joint health in subjects with severe haemophilia A treated prophylactically with recombinant factor VIII Fc fusion protein. Haemophilia. 2018;24(1):77–84. doi:10.1111/hae.13353
   PubMed Web of Science ®Google Scholar
• Warren BB, Jacobson L, Kempton C, et al. Factor VIII prophylaxis effects outweigh other hemostasis contributors in predicting severe haemophilia A joint outcomes. Haemophilia. 2019;25(5):867–875. doi:10.1111/hae.13778
   Web of Science ®Google Scholar
• Fischer K, van der Bom JG, Mauser-Bunschoten EP, et al. The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia. Blood. 2002;99(7):2337–2341. doi:10.1182/blood.V99.7.2337
   PubMed Web of Science ®Google Scholar
• Bladen M, Main E, Hubert N, Koutoumanou E, Liesner R, Khair K. Factors affecting the haemophilia joint health score in children with severe haemophilia. Haemophilia. 2013;19(4):626–631. doi:10.1111/hae.12108
   PubMed Web of Science ®Google Scholar
• Nijdam A, Foppen W, van der Schouw YT, Mauser-Bunschoten EP, Schutgens REG, Fischer K. Long-term effects of joint bleeding before starting prophylaxis in severe haemophilia. Haemophilia. 2016;22(6):852–858. doi:10.1111/hae.12959
   Web of Science ®Google Scholar
• Warren BB, Thornhill D, Stein J, et al. Young adult outcomes of childhood prophylaxis for severe hemophilia A: results of the Joint Outcome Continuation Study. Blood Adv. 2020;4(11):2451–2459. doi:10.1182/bloodadvances.2019001311
   PubMed Web of Science ®Google Scholar
• Nijdam A, Foppen W, De Kleijn P, et al. Discontinuing early prophylaxis in severe haemophilia leads to deterioration of joint status despite low bleeding rates. Thromb Haemost. 2016;115(5):931–938. doi:10.1160/TH15-08-0637
   Web of Science ®Google Scholar
• Fischer K, Van Der Bom JG, Prejs R, et al. Discontinuation of prophylactic therapy in severe haemophilia: incidence and effects on outcome. Haemophilia. 2001;7(6):544–550. doi:10.1046/j.1365-2516.2001.00560.x
   PubMed Web of Science ®Google Scholar
• Wallny TA, Scholz DT, Oldenburg J, et al. Osteoporosis in haemophilia - an underestimated comorbidity? Haemophilia. 2007;13(1):79–84. doi:10.1111/j.1365-2516.2006.01405.x
   Web of Science ®Google Scholar
• Nair AP, Jijina F, Ghosh K, Madkaikar M, Shrikhande M, Nema M. Osteoporosis in young haemophiliacs from western India. Am J Hematol. 2007;82(6):453–457. doi:10.1002/ajh.20877
   Web of Science ®Google Scholar
• Abdelrazik N, Reda M, El-Ziny M, Rabea H. Evaluation of bone mineral density in children with hemophilia: mansoura University children hospital (MUCH) experience, Mansoura, Egypt. Hematology. 2007;12(5):431–437. doi:10.1080/10245330701383700
   PubMed Web of Science ®Google Scholar
• Alioglu B, Selver B, Ozsoy H, Koca G, Ozdemir M, Dallar Y. Evaluation of bone mineral density in Turkish children with severe haemophilia A: Ankara hospital experience. Haemophilia. 2012;18(1):69–74. doi:10.1111/j.1365-2516.2011.02587.x
   Web of Science ®Google Scholar
• Naderi A, Nikvarz M, Arasteh M, Shokoohi M. Osteoporosis/osteopenia and hemophilic arthropathy in severe hemophilic patients. Arch Iran Med. 2012;15(2):82–84. doi:10.12152/AIM.006
   Web of Science ®Google Scholar
• Anagnostis P, Vakalopoulou S, Slavakis A, et al. Reduced bone mineral density in patients with haemophilia A and B in Northern Greece. Thromb Haemost. 2012;107(3):545–551. doi:10.1160/TH11-08-05563
   Web of Science ®Google Scholar
• Anagnostis P, Vakalopoulou S, Vyzantiadis TA, et al. The clinical utility of bone turnover markers in the evaluation of bone disease in patients with haemophilia A and B. Haemophilia. 2014;20(2):268–275. doi:10.1111/hae.12271
   Web of Science ®Google Scholar
• El-Mikkawy DME, Elbadawy MA, Abd El-Ghany SM, Samaha D. Serum sclerostin level and bone mineral density in pediatric hemophilic arthropathy. Indian J Pediatr. 2019;86(6):515–519. doi:10.1007/s12098-019-02855-1
   Web of Science ®Google Scholar
• Wells AJ, McLaughlin P, Simmonds JV, et al. A case-control study assessing bone mineral density in severe haemophilia A in the UK. Haemophilia. 2015;21(1):109–115. doi:10.1111/hae.12565
   Web of Science ®Google Scholar
• Kempton CL, Antun A, Antoniucci DM, et al. Bone density in haemophilia: a single institutional cross-sectional study. Haemophilia. 2014;20(1):121–128. doi:10.1111/hae.12240
   PubMed Web of Science ®Google Scholar
• Kiper Unal HD, Comert Ozkan M, Atilla FD, et al. Evaluation of bone mineral density and related parameters in patients with haemophilia: a single center cross-sectional study. Am J Blood Res. 2017;7(5):59–66.
   PubMed Web of Science ®Google Scholar
• Harris S, Boggio LN. Exercise may decrease further destruction in the adult haemophilic joint. Haemophilia. 2006;12(3):237–240. doi:10.1111/j.1365-2516.2006.01214.x
   Web of Science ®Google Scholar
• Groen WG, Takken T, van der Net J, Helders PJ, Fischer K. Habitual physical activity in Dutch children and adolescents with haemophilia. Haemophilia. 2011;17(5):e906–e912. doi:10.1111/j.1365-2516.2011.02555.x
   Web of Science ®Google Scholar
• Cuesta-Barriuso R, Torres-Ortuno A, Pérez-Alenda S, Jose Carrasco J, Querol F, Nieto-Munuera J. Sporting activities and quality of life in children with hemophilia: an observational study. Pediatr Phys Ther. 2016;28(4):453–459. doi:10.1097/PEP.0000000000000296
   Web of Science ®Google Scholar
• Timmer MA, Veenhof C, de Kleijn P, de Bie RA, Schutgens REG, Pisters MF. Movement behaviour patterns in adults with haemophilia. Ther Adv Hematol. 2020;11:2040620719896959. doi:10.1177/2040620719896959
   Web of Science ®Google Scholar
• Doria AS, Keshava SN, Mohanta A, et al. Diagnostic accuracy of ultrasound for assessment of hemophilic arthropathy: MRI correlation. Am J Roentgenol. 2015;204(3):W336–W347. doi:10.2214/AJR.14.12501
   PubMed Web of Science ®Google Scholar
• De la Corte-rodriguez H, Rodriguez-Merchan EC, Alvarez-Roman MT, Martin-Salces M, Martinoli C, Jimenez-Yuste V. The value of HEAD-US system in detecting subclinical abnormalities in joints of patients with hemophilia. Expert Rev Hematol. 2018;11(3):253–261. doi:10.1080/17474086.2018.1435269
   PubMed Web of Science ®Google Scholar
• Foppen W, van der Schaaf IC, Beek FJA, Mali WPTM, Fischer K. MRI predicts 5-year joint bleeding and development of arthropathy on radiographs in hemophilia. Blood Adv. 2020;4(1):113–121. doi:10.1182/bloodadvances.2019001238
   PubMed Web of Science ®Google Scholar
• Foppen W, van der Schaaf IC, Beek FJA, Mali WPTM, Fischer K. Diagnostic accuracy of point-of-care ultrasound for evaluation of early blood-induced joint changes: comparison with MRI. Haemophilia. 2018;24(6):971–979. doi:10.1111/hae.13524
   Web of Science ®Google Scholar
• von Drygalski A, Moore RE, Nguyen S, et al. Advanced hemophilic arthropathy: sensitivity of soft tissue discrimination with musculoskeletal ultrasound. J Ultrasound Med. 2018;37(8):1945–1956. doi:10.1002/jum.14541
   PubMed Web of Science ®Google Scholar
• Poonnoose PM, Hilliard P, Doria AS, et al. Correlating clinical and radiological assessment of joints in haemophilia: results of a cross sectional study. Haemophilia. 2016;22(6):925–933. doi:10.1111/hae.13023
   Web of Science ®Google Scholar
• Klukowska A, Czyrny Z, Laguna P, Brzewski M, Serafin-Krol MA, Rokicka-Milewska R. Correlation between clinical, radiological and ultrasonographical image of knee joints in children with haemophilia. Haemophilia. 2001;7(3):286–292. doi:10.1046/j.1365-2516.2001.00509.x
   Web of Science ®Google Scholar
• Fischer K, Nijdam A, Holmstrom M, et al. Evaluating outcome of prophylaxis in haemophilia: objective and self-reported instruments should be combined. Haemophilia. 2016;22(2):e80–e86. doi:10.1111/hae.12901
   Web of Science ®Google Scholar
• Pergantou H, Matsinos G, Papadopoulos A, Platokouki H, Aronis S. Comparative study of validity of clinical, X-ray and magnetic resonance imaging scores in evaluation and management of haemophilic arthropathy in children. Haemophilia. 2006;12(3):241–247. doi:10.1111/j.1365-2516.2006.01208.x
   PubMed Web of Science ®Google Scholar
• Feldman BM, Funk SM, Bergstrom BM, et al. Validation of a new pediatric joint scoring system from the International Hemophilia Prophylaxis Study Group: validity of the hemophilia joint health score. Arthritis Care Res. 2011;63(2):223–230. doi:10.1002/acr.20353
   Web of Science ®Google Scholar
• Fischer K, de Kleijn P. Using the Haemophilia Joint Health Score for assessment of teenagers and young adults: exploring reliability and validity. Haemophilia. 2013;19(6):944–950. doi:10.1111/hae.12197
   Web of Science ®Google Scholar
• Oymak Y, Yildirim AT, Yaman Y, et al. The effectiveness of tools for monitoring hemophilic arthropathy. J Pediatr Hematol Oncol. 2015;37(2):e80–e85. doi:10.1097/MPH.0000000000000210
   Web of Science ®Google Scholar
• Timmer MA, Foppen W, Schutgens RE, Pisters MF, Fischer K. Comparing findings of routine haemophilia joint health score and haemophlia early arthropathy detection with ultrasound assessments in adults with haemophilia. Haemophilia. 2017;23(2):e141–e143. doi:10.1111/hae.13147
   Web of Science ®Google Scholar
• Seuser A, Kurnik K, Mahlein AK. Infrared thermography as a non-invasive tool to explore differences in the musculoskeletal system of children with hemophilia compared to an age-matched healthy group. Sensors. 2018;18(2):518. doi:10.3390/s18020518
   Web of Science ®Google Scholar
• Seuser A, Navarrete-Duran M, Auerswald G, Mancuso ME. Muscle function deterioration in patients with haemophilia: prospective experience from Costa Rica. Haemophilia. 2018;24(4):e230–e241. doi:10.1111/hae.13455
   Web of Science ®Google Scholar
• García-Massó X, Ye-Lin Y, Garcia-Casado J, Querol F, Gonzalez LM. Assessment of haemophilic arthropathy through balance analysis: a promising tool. Comput Methods Biomech Biomed Engin. 2019;22(4):418–425. doi:10.1080/10255842.2018.1561877
   PubMed Web of Science ®Google Scholar
• Iem DU, De Schepper AMA, Camerlinck M, Grobbee DE, Fischer K. Magnetic resonance imaging in teenagers and young adults with limited haemophilic arthropathy: baseline results from a prospective study. Haemophilia. 2011;17(6):926–930. doi:10.1111/j.1365-2516.2011.02513.x
   Web of Science ®Google Scholar
• Lundin B, Ljung R, Pettersson H. MRI scores of ankle joints in children with haemophilia–comparison with clinical data. Haemophilia. 2005;11(2):116–122. doi:10.1111/j.1365-2516.2005.01061.x
   Web of Science ®Google Scholar
• Chowdary P. Extended half-life recombinant products in haemophilia clinical practice – expectations, opportunities and challenges. Thromb Res. 2020;196:609–617. doi:10.1016/j.thromres.2019.12.012
   Web of Science ®Google Scholar
• Zanon E, Tagliaferri A, Pasca S, et al. Physical activity improved by adherence to prophylaxis in an Italian population of children, adolescents and adults with severe haemophilia A: the SHAPE Study. Blood Transfus. 2020;18(2):152–158. doi:10.2450/2019.0040-19
   Web of Science ®Google Scholar
• Malec LM, Cheng D, Witmer CM, et al. The impact of extended half-life factor concentrates on prophylaxis for severe hemophilia in the United States. Am J Hematol. 2020;95(8):960–965. doi:10.1002/ajh.25844
   PubMed Web of Science ®Google Scholar
• Hua B, Olsen EHN, Sun S, et al. Serological biomarkers detect active joint destruction and inflammation in patients with haemophilic arthropathy. Haemophilia. 2017;23(4):e294–e300. doi:10.1111/hae.13196
   Web of Science ®Google Scholar
• Jansen NWD, Roosendaal G, Lundin B, et al. The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy. Arthritis Rheum. 2009;60(1):290–298. doi:10.1002/art.24184
   Web of Science ®Google Scholar
• Melchiorre D, Milia AF, Linari S, et al. RANK-RANKL-OPG in hemophilic arthropathy: from clinical and imaging diagnosis to histopathology. J Rheumatol. 2012;39(8):1678–1686. doi:10.3899/jrheum.120370
   Web of Science ®Google Scholar
• Manetti M, Linari S, Romano E, et al. TNF-alpha/TNF-R system may represent a crucial mediator of proliferative synovitis in hemophilia A. J Clin Med. 2019;8(7):939. doi:10.3390/jcm8070939
   Web of Science ®Google Scholar
• Parameswaran N, Patial S. Tumor necrosis factor-alpha signaling in macrophages. Crit Rev Eukaryot Gene Expr. 2010;20(2):87–103. doi:10.1615/CritRevEukarGeneExpr.v20.i2.10
   PubMed Web of Science ®Google Scholar
• von Drygalski A, Barnes RFW, Jang H, et al. Advanced magnetic resonance imaging of cartilage components in haemophilic joints reveals that cartilage hemosiderin correlates with joint deterioration. Haemophilia. 2019;25(5):851–858. doi:10.1111/hae.13802
   PubMed Web of Science ®Google Scholar
• Acharya SS, Kaplan RN, Macdonald D, Fabiyi OT, DiMichele D, Lyden D. Neoangiogenesis contributes to the development of hemophilic synovitis. Blood. 2011;117(8):2484–2493. doi:10.1182/blood-2010-05-284653
   PubMed Web of Science ®Google Scholar
• Zetterberg E, Palmblad J, Wallensten R, Morfini M, Melchiorre D, Holmström M. Angiogenesis is increased in advanced haemophilic joint disease and characterised by normal pericyte coverage. Eur J Haematol. 2014;92(3):256–262. doi:10.1111/ejh.12227
   PubMed Web of Science ®Google Scholar
• Rodriguez-Merchan EC, Valentino LA. Increased bone resorption in hemophilia. Blood Rev. 2019;33:6–10. doi:10.1016/j.blre.2018.05.002
   PubMed Web of Science ®Google Scholar
• Eldash HH, Atwa ZT, Saad MA. Vitamin D deficiency and osteoporosis in hemophilic children: an intermingled comorbidity. Blood Coagul Fibrinolysis. 2017;28(1):14–18. doi:10.1097/MBC.0000000000000519
   Web of Science ®Google Scholar
• Gamal Andrawes N, Hashem Fayek M, Salah El-Din N, Atef Mostafa R. Effect of low-dose factor VIII prophylaxis therapy on bone mineral density and 25(OH) vitamin D level in children with severe haemophilia A. Haemophilia. 2020;26(2):325–332. doi:10.1111/hae.13917
   Web of Science ®Google Scholar
• Abbasnezhad A, Habibi M, Abdolkarimi B, Zare S, Fazeli Moghadam E, Choghakhori R. Serum concentrations of vitamin D, calcium, phosphorus and trace minerals in adults and children with haemophilia A: association with disease severity, quality of life, joint health and functional status. Int J Hematol Oncol Stem Cell Res. 2020;14(1):56–71.
   Google Scholar
• Zhou JY, Barnes RFW, Foster G, Iorio A, Cramer TJ, von Drygalski A. Joint bleeding tendencies in adult patients with hemophilia: it’s not all pharmacokinetics. Clin Appl Thromb Hemost. 2019;25:1076029619862052. doi:10.1177/1076029619862052
   Web of Science ®Google Scholar
• Lobet S, Meite N, Koninckx MI, et al. Implementation and assessment of a self- and community-based rehabilitation programme in patients with haemophilia from Cote d’Ivoire. Haemophilia. 2019;25(5):859–866. doi:10.1111/hae.13833
   Web of Science ®Google Scholar
• Timmer MA, Kloek CJJ, de Kleijn P, et al. A blended physiotherapy intervention for persons with hemophilic arthropathy: development study. J Med Internet Res. 2020;22(6):e16631. doi:10.2196/16631
   Web of Science ®Google Scholar
• Hashem F, Stephensen D, Drechsler WI, et al. Muscle strengthening intervention for boys with haemophilia: developing and evaluating a best-practice exercise programme with boys, families and health-care professionals. Health Expectations. 2020;23:1350–1361.
   Web of Science ®Google Scholar